Crystal structure of β‐d‐galactofuranosidase from Streptomyces sp. JHA19 in complex with an inhibitor provides insights into substrate specificity

Noriki Fujio,Chihaya Yamada,Toma Kashima,Emiko Matsunaga,Robert J. Nash,Kaoru Takegawa,Shinya Fushinobu
DOI: https://doi.org/10.1002/1873-3468.15056
2024-11-19
FEBS Letters
Abstract:The crystal structure of β‐d‐galactofuranosidase belonging to glycoside hydrolase family 2 was determined in complex with a mechanism‐based potent inhibitor, d‐iminogalactitol. The inhibitor was bound to the enzyme with an integral hydrogen bond network. The extensive interactions in the active site allowed discrimination between β‐d‐galactofuranoside and α‐l‐arabinofuranoside substrates. d‐Galactofuranose (Galf) is widely distributed in glycoconjugates of pathogenic microbes. β‐d‐Galactofuranosidase (Galf‐ase) from Streptomyces sp. JHA19 (ORF1110) belongs to glycoside hydrolase (GH) family 2 and is the first identified Galf‐specific degradation enzyme. Here, the crystal structure of ORF1110 in complex with a mechanism‐based potent inhibitor, d‐iminogalactitol (Ki = 65 μm) was solved. ORF1110 binds to the C5–C6 hydroxy groups of d‐iminogalactitol with an extensive and integral hydrogen bond network, a key interaction that discriminates the substrates. The active site structure of ORF1110 is largely different from those of β‐glucuronidases and β‐galactosidases in the same GH2 family. A C‐terminal domain of ORF1110 is predicted to be a carbohydrate‐binding module family 42 that may bind Galf. The structural insights into Galf‐ase will contribute to the investigation of therapeutic tools against pathogens.
cell biology,biochemistry & molecular biology,biophysics
What problem does this paper attempt to address?